Register.

Open to fellows and faculty only. Part of the Helen Diller Family Comprehensive Cancer Center (HDFCCC) K12 Program's Concept to Completion, Strategies for Successful Clinical Trials Seminar Series, which aims to provide high-yield, practical information about designing, funding, and conducting patient-facing oncology trials.

Speakers:

• Rahul Aggarwal, MD - Associate Director for Clinical Sciences, UCSF Helen Diller Family Comprehensive Cancer Center; Associate Professor of Hematology/Oncology, UCSF

• Li Zhang, PhD – Professor of Medicine, UCSF

Learning Objectives:

• Describe the difference between objectives vs endpoints
• Identify basic biostatistical methods in therapeutic and nontherapeutic clinical oncology trials 
• Explain different types of innovative clinical trial design (e.g., phase 0, biomarker-driven, and adaptive designs)
• Discuss tips of the trade- accommodating a limited budget/sample size, the role of an interim analysis (futility, safety, efficacy), use of safety lead-ins
• Summarize tips for reviewing clinical data and pitfalls to avoid